Deaths Among CCP Elites Rise as COVID-19 Wave Hits China; China Claims Sufficient Drug Supply

⭕ Watch the full episode on EpochTV 👉https://ept.ms/ElitesDieinDroves_YT

🔴 THE FINAL WAR is a documentary that uncovers the Chinese Communist Party’s 100-year plot to defeat America.👉👉https://ept.ms/3V3NfV9

🔵 Sekur (promo code: Tiffany) 👉https://ept.ms/3yW0Wul

🔵 A Documentary by The Epoch Times, reveals the truth that has been hidden from the American people.👉 https://ept.ms/3cTR1zF

🔥 BEST OFFER EVER 👉 https://ept.ms/3ubSyX9

⭕️ Sign up for our NEWSLETTER and stay in touch👉https://www.ntd.com/newsletter.html
-
Deaths among #ChineseCommunistParty elites—rising in China. A recent #Outbreak of COVID-19 killing dozens of prominent scholars and officials.

#China says its medical supplies are sufficient. But reports tell another story.

TikTok's parent company admitting some employees accessed the user data of two journalists, without consent.

That—as some American universities join about 20 states in banning TikTok.

Illegal Fentanyl seized—enough to kill the entire population of the U.S. That’s how much the DEA found this year on American soil.

And, Chinese telecom giant Huawei pulling in more money from patents than it pays out. For the second straight year.

00:00 Intro
00:54 Deaths Among CCP Elites Rise as COVID-19 Wave Hits China
02:57 Chinese Article Details U.S. COVID-19 Deaths
04:43 China Claims Sufficient Drug Supply, Limits Sales
06:12 ByteDance Admits User Data Compromised
07:05 Some U.S. Universities Restrict TikTok on Campus
07:39 TikTok Spends Millions on Lobbying in U.S.: Report
08:23 DEA Seized 379M Fentanyl Doses in 2022
09:29 China Sanctions 2 Americans Over Actions in Tibet
10:22 Huawei Brings in More Patent Royalties Than It Pays
11:42 Must Look with a Non-Biased Lens: Rex Lee on Twitter Files
---------
💎 Support our work: https://donorbox.org/china-in-focus
⭕️ Subscribe YouTube👉https://www.youtube.com/channel/UCBOqkAGTtzZVmKvY4SwdZ2g?sub_confirmation=1

⭕️ Get NTD on TV 👉 http://www.NTD.com/TV

-------------------------------------------------

-------------------------------------------------
© All Rights Reserved.